Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
Dollar change
Percentage change
IndexS&P 500 P/E65.54 EPS (ttm)1.48 Insider Own75.13% Shs Outstand198.74M Perf Week3.32%
Market Cap19.23B Forward P/E24.85 EPS next Y3.89 Insider Trans-0.05% Shs Float198.74M Perf Month1.86%
Income294.20M PEG6.55 EPS next Q0.78 Inst Own99.55% Short Float1.41% Perf Quarter14.70%
Sales3.59B P/S5.35 EPS this Y8.11% Inst Trans-4.09% Short Ratio2.62 Perf Half Y3.60%
Book/sh38.14 P/B2.54 EPS next Y12.47% ROA2.54% Short Interest2.81M Perf Year14.34%
Cash/sh0.61 P/C159.04 EPS next 5Y10.00% ROE4.00% 52W Range75.93 - 99.90 Perf YTD2.26%
Dividend Est.- P/FCF89.43 EPS past 5Y15.98% ROI2.86% 52W High-3.16% Beta0.94
Dividend TTM0.03 (0.03%) Quick Ratio1.00 Sales past 5Y7.68% Gross Margin60.44% 52W Low27.41% ATR (14)2.04
Dividend Ex-DateJul 26, 2023 Current Ratio1.76 EPS Y/Y TTM-23.99% Oper. Margin14.84% RSI (14)57.90 Volatility2.27% 2.01%
Employees15000 Debt/Eq0.37 Sales Y/Y TTM8.61% Profit Margin8.19% Recom2.33 Target Price98.19
Option/ShortYes / Yes LT Debt/Eq0.36 EPS Q/Q28.04% Payout- Rel Volume1.21 Prev Close97.78
Sales Surprise0.27% EPS Surprise-0.26% Sales Q/Q9.31% EarningsFeb 29 AMC Avg Volume1.07M Price96.75
SMA202.67% SMA503.45% SMA2007.30% Trades Volume1,292,136 Change-1.05%
Date Action Analyst Rating Change Price Target Change
Feb-06-24Resumed KeyBanc Capital Markets Sector Weight
Oct-30-23Initiated BofA Securities Buy $380
Oct-05-23Downgrade Redburn Atlantic Overweight → Neutral $390 → $343
May-30-23Initiated Morgan Stanley Equal-Weight $410
Dec-22-22Initiated Mizuho Buy $375
Nov-30-22Upgrade Robert W. Baird Neutral → Outperform $345 → $375
Oct-12-22Downgrade Jefferies Buy → Hold $400 → $295
Aug-29-22Downgrade KeyBanc Capital Markets Overweight → Sector Weight
May-17-22Upgrade Citigroup Neutral → Buy $460 → $405
Apr-08-22Initiated Needham Hold
Feb-22-24 10:00AM
Feb-21-24 08:01PM
Feb-20-24 11:35AM
Feb-18-24 01:26PM
Feb-15-24 04:15PM
09:43AM Loading…
Feb-13-24 09:43AM
Feb-12-24 10:31AM
Feb-09-24 08:31AM
Jan-25-24 04:15PM
Jan-22-24 04:53AM
Jan-05-24 07:48AM
Dec-21-23 04:15PM
Dec-19-23 04:15PM
Dec-09-23 01:05AM
02:11PM Loading…
Dec-08-23 02:11PM
Dec-07-23 06:00PM
Dec-05-23 02:20PM
Dec-04-23 12:44PM
Nov-30-23 04:15PM
Nov-28-23 09:31AM
01:25AM Loading…
Nov-24-23 01:25AM
Nov-02-23 04:15PM
Nov-01-23 04:15PM
Oct-30-23 09:43AM
Oct-19-23 11:40AM
Oct-13-23 11:33AM
Sep-27-23 12:03PM
Sep-14-23 12:30PM
Sep-12-23 04:15PM
Sep-11-23 04:15PM
Sep-08-23 03:44PM
Sep-05-23 12:03PM
Aug-31-23 12:06PM
Aug-30-23 06:00PM
Aug-29-23 08:46AM
Aug-28-23 11:43AM
Aug-25-23 08:02AM
Aug-24-23 12:10PM
Aug-15-23 03:41PM
Aug-13-23 08:23AM
Aug-10-23 09:05PM
Aug-09-23 06:46AM
Aug-07-23 01:18PM
Aug-02-23 04:14PM
Jul-27-23 04:33PM
Jul-26-23 04:15PM
Jul-17-23 07:05AM
Jul-13-23 02:00PM
Jul-12-23 04:15PM
Jul-03-23 10:30AM
Jun-28-23 10:19AM
Jun-23-23 11:40AM
Jun-21-23 08:00PM
Jun-15-23 07:52PM
Jun-09-23 07:13PM
Jun-07-23 11:40AM
Jun-06-23 03:39PM
Jun-05-23 09:35AM
Jun-02-23 05:45PM
Jun-01-23 06:00PM
May-30-23 08:03AM
May-25-23 12:00PM
May-23-23 04:15PM
May-22-23 11:40AM
May-18-23 05:15AM
May-16-23 09:45AM
May-12-23 06:04AM
May-11-23 05:35PM
May-09-23 05:05PM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Andrews Brian GEVP, CFO & TreasurerJan 08Option Exercise0.0072302,996Jan 10 07:11 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Jan 08Option Exercise0.002,73804,028Jan 10 07:11 PM
McBride Daniel GEVP & Chief Operating OfficerJan 08Option Exercise0.001,04209,368Jan 10 07:11 PM
Ricupati AgostinoSVP & CAOJan 08Option Exercise0.0078601,710Jan 10 07:11 PM
Khadder NicholasVP, General Counsel & Corp SecJan 08Option Exercise0.002840325Jan 10 07:11 PM
Sheffield Holly RPresident, CSIJan 08Option Exercise0.0098605,564Jan 10 07:11 PM
PETERSMEYER GARY SDirectorJan 04Sale336.0315050,4042,297Jan 05 06:05 PM
WEISS ROBERT SDirectorDec 19Option Exercise175.3179,37013,914,355150,063Dec 21 05:25 PM
WEISS ROBERT SDirectorDec 19Sale364.8179,37028,955,13570,693Dec 21 05:25 PM
PETERSMEYER GARY SDirectorDec 14Sale368.55300110,5652,464Dec 14 07:15 PM
Sheffield Holly RPresident, CSIJun 04Option Exercise356.471,104393,5434,952Jun 07 02:45 PM
PETERSMEYER GARY SDirectorApr 01Option Exercise0.0063002,764Apr 03 06:30 PM
Jay ColleenDirectorApr 01Option Exercise0.0063005,977Apr 03 06:28 PM
KOZY WILLIAM ADirectorApr 01Option Exercise0.0066206,314Apr 03 06:29 PM
Rivas MariaDirectorApr 01Option Exercise0.0063001,132Apr 03 06:28 PM
MADDEN TERESA SDirectorApr 01Option Exercise0.0063001,686Apr 03 06:27 PM
Lucchese Cynthia LDirectorApr 01Option Exercise0.005120512Apr 03 06:25 PM
WEISS ROBERT SDirectorApr 01Option Exercise0.00693070,693Apr 03 06:31 PM
Ricupati AgostinoSVP & CAOMar 31Sale370.001,000370,000863Apr 03 06:32 PM
PETERSMEYER GARY SDirectorMar 15Sale335.78700235,0442,134Mar 15 04:18 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Mar 09Sale340.531,216414,0871,290Mar 09 06:03 PM
WEISS ROBERT SDirectorMar 07Option Exercise131.6037,5104,936,316107,510Mar 07 07:42 PM
WEISS ROBERT SDirectorMar 07Sale337.7237,51012,667,88070,000Mar 07 07:42 PM